Welcome to our dedicated page for ICON PLC SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ICON plc filings document current-report disclosures for a foreign private issuer in the clinical research organization sector. Form 6-K reports furnish press releases and exhibits on operating results, financial guidance, earnings-call scheduling, conference presentations, shareholder voting matters, governance updates, and clinical or regulatory disclosures.
The filings also record accounting-practices and internal-control matters, including revenue-recognition disclosures, as well as XBRL financial information covering operating results, equity accounts and reporting-segment data. These documents frame ICON’s public-company reporting around clinical development services, capital structure, governance and risk-related material events.
ICON plc (ICLR) insider filed a Form 144 to sell 18,901 common shares with an aggregate market value of $3,594,781.19. The shares are scheduled for sale on or about 10/02/2025 on NASDAQ.
The filing shows the 18,901 shares were acquired on 10/01/2025 as restricted stock that vested under a registered plan and were issued by the issuer for services rendered. The filing reports 77,772,130 shares outstanding and indicates no securities sold by the filer in the past three months.
ICON plc filed a Form 6-K as a foreign private issuer for September 2025. The filing mainly provides an exhibit stating that ICON plc has scheduled its third quarter 2025 earnings conference call. The report is signed on behalf of the company by Chief Financial Officer Nigel Clerkin.
ICON plc submitted a Form 6-K as a foreign private issuer for September 2025, mainly to provide investors with a press release about a CEO transition.
The filing lists a single exhibit, a press release dated September 4, 2025 titled “ICON Announces CEO Transition,” indicating a planned leadership change at the chief executive level, though specific details of the transition are contained in the attached press release rather than this summary document.
ICON plc, an Ireland-based company, submitted a routine report as a foreign private issuer and indicated it files its annual reports on Form 20-F. The report mainly highlights that ICON plc plans to participate in upcoming investor conferences, signaling continued engagement with the investment community.
Artisan Partners filed Amendment No. 1 to a Schedule 13G reporting a beneficial ownership position in ICON plc Ordinary Shares (CUSIP G4705A100). The filing discloses ownership of 7,184,870 shares, equal to 9.0% of the class based on 79,483,795 shares outstanding as of 06/05/2025. The reporting group reports no sole voting or dispositive power, shared voting power of 6,946,790 and shared dispositive power of 7,184,870.
The statement notes that 5,518,132 of the shares are held on behalf of Artisan Funds and that the shares were acquired on behalf of discretionary clients of Artisan Partners Limited Partnership. The filing certifies the holdings are in the ordinary course of business and not intended to change control and is signed by Gregory K. Ramirez. A joint filing agreement is included as an exhibit.
Icon Plc (ICLR) submitted a Form 144 notice reporting a proposed sale of 381 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $59,992.98. The form lists 77,772,130 shares outstanding and shows the shares were acquired on 08/07/2025 by restricted stock vesting under a registered plan and are to be sold on or about 08/08/2025. The filing reports Nothing to Report for securities sold in the past three months.
The notice includes the filer’s representation that they are unaware of undisclosed material adverse information. Several issuer/filer identification fields in the form are left blank in the provided content.
Icon Plc filed a Rule 144 notice proposing the sale of 1,136 common shares with an aggregate market value of $178,876.72. The sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 08/08/2025. The filing reports 77,772,130 shares outstanding, giving context to the size of this proposed transaction.
The securities were acquired on 08/07/2025 as restricted stock vesting under a registered plan from the issuer and the stated nature of payment is services rendered. The filer reports nothing to report for securities sold during the past three months and includes the standard representation that the signer knows of no undisclosed material adverse information about the issuer.